Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic Effects of B-Type Natriuretic Peptide and Potentiates B-Type Natriuretic Peptide Effects in Failing But Not Normal Canine Heart-Reference-Cited by-同舟云学术

Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic Effects of B-Type Natriuretic Peptide and Potentiates B-Type Natriuretic Peptide Effects in Failing But Not Normal Canine Heart

Published:2007-03 Issue:10 Volume:49 Page:1079-1088
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Forfia Paul R.,Lee Myung,Tunin Richard S.,Mahmud Mobusher,Champion Hunter C.,Kass David A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Natriuretic peptides;Levin;N Engl Med,1998

2. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure;Hirooka;Circulation,1990

3. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure;Nakamura;Am Heart J,1998

4. Atrial natriuretic factor in normal subjects and heart failure patients;Cody;J Clin Invest,1986

5. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A;Kuhn;Circ Res,2003

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial;Journal of the American Heart Association;2024-04-02

2. The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload;Pharmacology Research & Perspectives;2024-01-29

3. Combined Inhibition of Phosphodiesterase-5 and -9 in Experimental Heart Failure;JACC: Heart Failure;2024-01

4. Pharmacologic blockade of the natriuretic peptide clearance receptor promotes weight loss and enhances insulin sensitivity in type 2 diabetes;Translational Research;2023-05

5. Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial;Circulation: Heart Failure;2023-01-25